The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes following melanoma metastasectomy categorized by response to immune checkpoint inhibitor (ICI) therapy.
 
Aravind Sreeram
No Relationships to Disclose
 
Sabrina Lin
No Relationships to Disclose
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; EyePoint Pharmaceuticals (I); Kyverna Therapeutics (I); Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - AACR Project GENIE; The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation
 
Parisa Momtaz
No Relationships to Disclose
 
Monica Chen
Stock and Other Ownership Interests - docs; FIGS; Nordisk; Quest Diagnostics
Consulting or Advisory Role - Candel Therapeutics
Research Funding - ASCO; NIH
Travel, Accommodations, Expenses - AACR; ASCO
 
Edmund Bartlett
Consulting or Advisory Role - QBiotics Group
Research Funding - QBiotics Group (Inst); Skyline Diagnostics (Inst)
 
Mary Brady
No Relationships to Disclose
 
Michael Postow
Consulting or Advisory Role - Bristol-Myers Squibb; Cancer Expert Now; Chugai Pharma; Eisai; Erasca, Inc; Intellisphere; Lyvgen Biopharma; Merck; MJH Associates; Nektar; Novartis; Pfizer; WebMD
Research Funding - Array BioPharma (Inst); BioAtla (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImaginAb (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst)
 
James Smithy
Consulting or Advisory Role - Bristol-Myers Squibb; IO Biotech; Iovance Biotherapeutics
Research Funding - Daiichi Sankyo (Inst); IO Biotech (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Immatics
 
Charlotte Ariyan
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
Consulting or Advisory Role - Iovance Biotherapeutics; Merck
Speakers' Bureau - Bristol-Myers Squibb
 
Alexander Shoushtari
Consulting or Advisory Role - Erasca, Inc; Immunocore
Research Funding - Bristol-Myers Squibb (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Mural Oncology (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Danielle Bello
No Relationships to Disclose